Microbiota-induced active translocation of peptidoglycan across the intestinal barrier dictates its within-host dissemination

Peptidoglycan, the major structural polymer forming the cell wall of bacteria, is an important mediator of physiological and behavioral effects in mammalian hosts. These effects are frequently linked to its translocation from the intestinal lumen to host tissues. However, the modality and regulation...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 120; no. 4; p. e2209936120
Main Authors: Wheeler, Richard, Bastos, Paulo André Dias, Disson, Olivier, Rifflet, Aline, Gabanyi, Ilana, Spielbauer, Julia, Bérard, Marion, Lecuit, Marc, Boneca, Ivo Gomperts
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 24-01-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peptidoglycan, the major structural polymer forming the cell wall of bacteria, is an important mediator of physiological and behavioral effects in mammalian hosts. These effects are frequently linked to its translocation from the intestinal lumen to host tissues. However, the modality and regulation of this translocation across the gut barrier has not been precisely addressed. In this study, we characterized the absorption of peptidoglycan across the intestine and its systemic dissemination. We report that peptidoglycan has a distinct tropism for host organs when absorbed via the gut, most notably by favoring access to the brain. We demonstrate that intestinal translocation of peptidoglycan occurs through a microbiota-induced active process. This process is regulated by the parasympathetic pathway via the muscarinic acetylcholine receptors. Together, this study reveals fundamental parameters concerning the uptake of a major microbiota molecular signal from the steady-state gut.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC9942837
Edited by Jeffrey Gordon, Washington University in St Louis School of Medicine, St. Louis, MO; received June 9, 2022; accepted November 22, 2022
1R.W., P.A.D.B., O.D., and A.R. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2209936120